Healthcare & Life Sciences
Cerevance
Netherlandscerevance.com/
Cerevance is a series b startup based in United States. 1 investor tracked.
activeseries-c-plus
series-c-plus
Stage
2017
Founded
2
Investors
About Cerevance
Cerevance is a startup founded in 2017 based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cerevance is a clinical-stage biopharmaceutical company focused on advancing cell type-specific therapies for neurodegenerative diseases and obesity, utilizing its proprietary NETSseq platform to identify novel therapeutic targets from human brain tissue samples.
Explore Cerevance's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.